Pilotti, V <br/><br/>
Transfer factor as an adjuvant to non-small cell lung cancer (NSCLC) therapy.  [electronic resource] 

 -  Biotherapy (Dordrecht, Netherlands)  1996 
 - 117-21 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0921-299X 
<br/><br/><label>Standard No.: </label>10.1007/BF02628668  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--adverse effects<br/>Aged<br/>Aged, 80 and over<br/>Carcinoma, Non-Small-Cell Lung--pathology<br/>Combined Modality Therapy<br/>Female<br/>Humans<br/>Immunotherapy<br/>Longitudinal Studies<br/>Lung Neoplasms--pathology<br/>Male<br/>Middle Aged<br/>Neoplasm Recurrence, Local<br/>Neoplasm Staging<br/>Transfer Factor--adverse effects